Wikipedia The Free Encyclopedia.: Unterschied zwischen den Versionen
K |
K |
||
| Zeile 1: | Zeile 1: | ||
| − | + | Prior to starting SABRIL, tell your medical professional concerning every one of your (or your kid's) medical problems consisting of clinical depression, mood troubles, suicidal thoughts [https://www.symbaloo.com/embed/shared/AAAABAjNezMAA41_lmp9kg== vigabatrin trade name] or behavior, any allergic reaction to SABRIL, vision issues, kidney troubles, low red cell matters (anemia), and any type of nervous or psychological disease.<br><br>The Vigabatrin REMS Program is required by the FDA to make sure informed risk-benefit choices prior to launching treatment, and to ensure appropriate use vigabatrin while patients are dealt with. It is not feasible for your doctor to know when vision loss will certainly occur. <br><br>It is suggested that your healthcare provider test your (or your child's) vision prior to or within 4 weeks after starting SABRIL and a minimum of every 3 months during therapy until SABRIL is stopped. Tell your healthcare provider if you or your child have any kind of side effect that bothers you or that does not disappear.<br><br>Inform your healthcare provider if you are expecting or mean to get pregnant. If vision testing can not be done, your doctor may continue recommending SABRIL, however will not be able to watch for any kind of vision loss. If vision examinations are refrained routinely, your doctor may quit suggesting SABRIL for you (or your child). | |
Version vom 7. Mai 2024, 14:34 Uhr
Prior to starting SABRIL, tell your medical professional concerning every one of your (or your kid's) medical problems consisting of clinical depression, mood troubles, suicidal thoughts vigabatrin trade name or behavior, any allergic reaction to SABRIL, vision issues, kidney troubles, low red cell matters (anemia), and any type of nervous or psychological disease.
The Vigabatrin REMS Program is required by the FDA to make sure informed risk-benefit choices prior to launching treatment, and to ensure appropriate use vigabatrin while patients are dealt with. It is not feasible for your doctor to know when vision loss will certainly occur.
It is suggested that your healthcare provider test your (or your child's) vision prior to or within 4 weeks after starting SABRIL and a minimum of every 3 months during therapy until SABRIL is stopped. Tell your healthcare provider if you or your child have any kind of side effect that bothers you or that does not disappear.
Inform your healthcare provider if you are expecting or mean to get pregnant. If vision testing can not be done, your doctor may continue recommending SABRIL, however will not be able to watch for any kind of vision loss. If vision examinations are refrained routinely, your doctor may quit suggesting SABRIL for you (or your child).
